News
Medtronic PLC (MDT) reports robust organic growth and strategic initiatives, including a Diabetes business spin-off, to ...
Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...
Medtronic plc revealed plans to spin off its underperforming diabetes unit as a separate public company during its fourth ...
The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...
Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...
The company says it plans to separate the two entities within 18 months but will still need to get the approval of the ...
An 18-year-old has admitted to being one of two teenagers who shot and wounded nine people, at least four of them juveniles, ...
Medtronic plc (NYSE:MDT) declared a 1.4% hike in its dividend, which took its quarterly dividend to $0.71 per share. Medtronic plc (NYSE:MDT) is a leading medical device maker with operations spanning ...
Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.
Medtronic's Q4 2025 earnings reveal 5.4% growth, Diabetes segment spin-off plans, and strategic focus on high-margin growth drivers.
The medical device maker has been working to turn around the division over the past few years.
Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results